BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35453142)

  • 1. Association of Baseline and Longitudinal Changes in Frailty Burden and Risk of Heart Failure in Type 2 Diabetes-Findings from the Look AHEAD Trial.
    Pandey A; Khan MS; Garcia K; Simpson F; Bahnson J; Patel KV; Singh S; Vaduganathan M; Bertoni A; Kitzman D; Johnson K; Lewis CE; Espeland MA
    J Gerontol A Biol Sci Med Sci; 2022 Dec; 77(12):2489-2497. PubMed ID: 35453142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Intensive Lifestyle Intervention, Fitness, and Body Mass Index With Risk of Heart Failure in Overweight or Obese Adults With Type 2 Diabetes Mellitus: An Analysis From the Look AHEAD Trial.
    Pandey A; Patel KV; Bahnson JL; Gaussoin SA; Martin CK; Balasubramanyam A; Johnson KC; McGuire DK; Bertoni AG; Kitzman D; Berry JD;
    Circulation; 2020 Apr; 141(16):1295-1306. PubMed ID: 32134326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition).
    Pandey A; Khan H; Newman AB; Lakatta EG; Forman DE; Butler J; Berry JD
    Hypertension; 2017 Feb; 69(2):267-274. PubMed ID: 27993954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study.
    Freiberg MS; Chang CH; Skanderson M; Patterson OV; DuVall SL; Brandt CA; So-Armah KA; Vasan RS; Oursler KA; Gottdiener J; Gottlieb S; Leaf D; Rodriguez-Barradas M; Tracy RP; Gibert CL; Rimland D; Bedimo RJ; Brown ST; Goetz MB; Warner A; Crothers K; Tindle HA; Alcorn C; Bachmann JM; Justice AC; Butt AA
    JAMA Cardiol; 2017 May; 2(5):536-546. PubMed ID: 28384660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic Markers and Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Echouffo-Tcheugui JB; Ogunmoroti O; Golden SH; Bertoni AG; Mongraw-Chaffin M; Pandey A; Ndumele CE; Michos ED
    J Card Fail; 2022 Nov; 28(11):1593-1603. PubMed ID: 35114382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Baseline and Longitudinal Changes in Body Composition Measures With Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings From the Look AHEAD Trial.
    Patel KV; Bahnson JL; Gaussoin SA; Johnson KC; Pi-Sunyer X; White U; Olson KL; Bertoni AG; Kitzman DW; Berry JD; Pandey A;
    Circulation; 2020 Dec; 142(25):2420-2430. PubMed ID: 33164570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prefrailty, impairment in physical function, and risk of incident heart failure among older adults.
    Segar MW; Singh S; Goyal P; Hummel SL; Maurer MS; Forman DE; Butler J; Pandey A
    J Am Geriatr Soc; 2021 Sep; 69(9):2486-2497. PubMed ID: 34050919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary quality and risk of heart failure in men.
    Gu X; Wang DD; Fung TT; Mozaffarian D; Djoussé L; Rosner B; Sacks FM; Willett WC
    Am J Clin Nutr; 2022 Aug; 116(2):378-385. PubMed ID: 35511594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal cardiometabolic health and risk of heart failure in type 2 diabetes: an analysis from the Look AHEAD trial.
    Patel KV; Khan MS; Segar MW; Bahnson JL; Garcia KR; Clark JM; Balasubramanyam A; Bertoni AG; Vaduganathan M; Farkouh ME; Januzzi JL; Verma S; Espeland M; Pandey A
    Eur J Heart Fail; 2022 Nov; 24(11):2037-2047. PubMed ID: 36280384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Prognostic Significance of Frailty in Asian Patients With Heart Failure: Insights From ASIAN-HF.
    Aung T; Qin Y; Tay WT; Binte Salahudin Bamadhaj NS; Chandramouli C; Ouwerkerk W; Tromp J; Anand I; Richards AM; Hung CL; Teramoto K; Katherine Teng TH; Lam CSP
    JACC Asia; 2021 Dec; 1(3):303-313. PubMed ID: 36341220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical frailty and long-term mortality in older people with chronic heart failure with preserved and reduced ejection fraction: a retrospective longitudinal study.
    Weng SC; Lin CS; Tarng DC; Lin SY
    BMC Geriatr; 2021 Feb; 21(1):92. PubMed ID: 33522908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study.
    Binnenmars SH; Hoogslag GE; Yeung SMH; Brouwers FP; Bakker SJL; van Gilst WH; Gansevoort RT; Navis G; Voors AA; de Borst MH
    J Am Heart Assoc; 2022 Aug; 11(15):e024952. PubMed ID: 35876420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction.
    Hamada T; Kubo T; Kawai K; Nakaoka Y; Yabe T; Furuno T; Yamada E; Kitaoka H;
    ESC Heart Fail; 2022 Jun; 9(3):1853-1863. PubMed ID: 35355441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial.
    Pandey A; Segar MW; Singh S; Reeves GR; O'Connor C; Piña I; Whellan D; Kraus WE; Mentz RJ; Kitzman DW
    Circulation; 2022 Jul; 146(2):80-90. PubMed ID: 35616018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME Trial.
    Savarese G; Uijl A; Lund LH; Anker SD; Asselbergs F; Fitchett D; Inzucchi SE; Koudstaal S; Ofstad AP; Schrage B; Vedin O; Wanner C; Zannad F; Zwiener I; Butler J
    J Card Fail; 2021 Aug; 27(8):888-895. PubMed ID: 34364665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ankle-brachial index and incident heart failure with reduced versus preserved ejection fraction: The Multi-Ethnic Study of Atherosclerosis.
    Prasada S; Shah SJ; Michos ED; Polak JF; Greenland P
    Vasc Med; 2019 Dec; 24(6):501-510. PubMed ID: 31480898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total brachial artery reactivity and incident heart failure and heart failure subtypes: multi-ethnic study of atherosclerosis.
    Charry D; Xu J; Tanaka H; Heffernan KS; Richardson MR; Churilla JR
    Heart Vessels; 2022 Mar; 37(3):411-418. PubMed ID: 34436657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
    Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
    ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.